Health Care: Drugs

Ligand Pharmaceuticals Inc. (LGND: NASDAQ)

$64.13 n/a | n/a%
04/17/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 64.13
52 Week High 80.42
52 Week Low 25.60
Avg. Daily Vol. (Mil) 0.38
Beta (3 year) 1.00
Share Related Items
Mkt Cap (Mil) 1,322.01
Shares Out (Mil) 20.61
Float (Mil) 14.22
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.80
Current Ratio 0.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.18
Valuation Ratios
Price Earnings 116.60
Price/Sales 26.99
Price/Book 26.65
Price/Cash Flow 91.20
Per Share Data
Earnings 0.55
Sales 2.38
Book Value 2.41
Cash Flow 0.70
Business Summary
Ligand Pharmaceuticals, Inc. is a biotechnology company that operates with a business model focused on developing or acquiring assets. It is engaged in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 20
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 3.34
Previous Month (Mil) 3.37
Short Interest Ratio (Days) 8.90
Management Effectiveness
Return on Equity 23.00
Return on Assets 10.90
Return on Investments 23.00
Profitability
Gross Margin 94.60
EBIT Margin 23.00
Profit Margin 23.30

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter